Press releases – AlzeCure Pharma

April 1, 2026

AlzeCure Pharma to present at Redeye Alzheimer’s Theme Event on April 9

March 19, 2026

AlzeCure presents new preclinical data with NeuroRestore ACD856 at the Alzheimer’s Conference AD/PD

March 4, 2026

AlzeCure Pharma to present at Stora Aktiedagarna in Stockholm on March 11

February 24, 2026

Pain project ACD440 granted orphan drug status in the EU

February 3, 2026

AlzeCure abstract on NeuroRestore ACD856 accepted at the Alzheimer’s conference AP/PD 2026

February 2, 2026

AlzeCure Pharma selected to present at the Bio-Neuroscience conference in Amsterdam